{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T13:02:22Z","timestamp":1794747742247,"version":"4.9.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"7916","license":[{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2022,6,30]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The liver takes up bile salts from blood to generate bile, enabling absorption of lipophilic nutrients and excretion of metabolites and drugs<jats:sup>1<\/jats:sup>. Human Na<jats:sup>+<\/jats:sup>\u2013taurocholate co-transporting polypeptide (NTCP) is the main bile salt uptake system in liver. NTCP is also the cellular entry receptor of human hepatitis B and D viruses<jats:sup>2,3<\/jats:sup> (HBV\/HDV), and has emerged as an important target for antiviral drugs<jats:sup>4<\/jats:sup>. However, the molecular mechanisms underlying NTCP transport and viral receptor functions remain incompletely understood. Here we present cryo-electron microscopy structures of human NTCP in complexes with nanobodies, revealing key conformations of its transport cycle. NTCP undergoes a conformational transition\u00a0opening a wide transmembrane pore that serves as the transport pathway for bile salts, and exposes key determinant residues for HBV\/HDV binding to the outside of the cell. A nanobody that stabilizes pore closure and inward-facing states impairs recognition of the HBV\/HDV receptor-binding domain preS1, demonstrating binding selectivity of the viruses for open-to-outside over inward-facing conformations of the NTCP transport cycle. These results provide molecular insights into NTCP \u2018gated-pore\u2019 transport and HBV\/HDV receptor recognition mechanisms, and are expected to help with development of liver disease therapies targeting NTCP.<\/jats:p>","DOI":"10.1038\/s41586-022-04723-z","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T16:08:51Z","timestamp":1652285331000},"page":"1015-1020","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Structural basis of sodium-dependent bile salt uptake into the liver"],"prefix":"10.1038","volume":"606","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3709-8203","authenticated-orcid":false,"given":"Kapil","family":"Goutam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5272-0865","authenticated-orcid":false,"given":"Francesco S.","family":"Ielasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2466-0172","authenticated-orcid":false,"given":"Els","family":"Pardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3825-874X","authenticated-orcid":false,"given":"Jan","family":"Steyaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6618-8307","authenticated-orcid":false,"given":"Nicolas","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,11]]},"reference":[{"key":"4723_CR1","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/B978-0-12-394316-3.00004-1","volume":"70","author":"B Doring","year":"2012","unstructured":"Doring, B., Lutteke, T., Geyer, J. & Petzinger, E. The SLC10 carrier family: transport functions and molecular structure. Curr. Top. Membr. 70, 105\u2013168 (2012).","journal-title":"Curr. Top. Membr."},{"key":"4723_CR2","doi-asserted-by":"publisher","first-page":"e00049","DOI":"10.7554\/eLife.00049","volume":"1","author":"H Yan","year":"2012","unstructured":"Yan, H. et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. eLife 1, e00049 (2012).","journal-title":"eLife"},{"key":"4723_CR3","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","volume":"146","author":"Y Ni","year":"2014","unstructured":"Ni, Y. et al. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology 146, 1070\u20131083 (2014).","journal-title":"Gastroenterology"},{"key":"4723_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000360948","volume":"57","author":"FA Lempp","year":"2014","unstructured":"Lempp, F. A. & Urban, S. Inhibitors of hepatitis B virus attachment and entry. Intervirology 57, 151\u2013157 (2014).","journal-title":"Intervirology"},{"key":"4723_CR5","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s00424-003-1130-z","volume":"447","author":"B Hagenbuch","year":"2004","unstructured":"Hagenbuch, B. & Dawson, P. The sodium bile salt cotransport family SLC10. Pflugers Arch. 447, 566\u2013570 (2004).","journal-title":"Pflugers Arch."},{"key":"4723_CR6","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.mam.2012.07.004","volume":"34","author":"T Claro da Silva","year":"2013","unstructured":"Claro da Silva, T., Polli, J. E. & Swaan, P. W. The solute carrier family 10 (SLC10): beyond bile acid transport. Mol. Aspects Med. 34, 252\u2013269 (2013).","journal-title":"Mol. Aspects Med."},{"key":"4723_CR7","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1172\/JCI117091","volume":"93","author":"B Hagenbuch","year":"1994","unstructured":"Hagenbuch, B. & Meier, P. J. Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+\/bile acid cotransporter. J. Clin. Invest. 93, 1326\u20131331 (1994).","journal-title":"J. Clin. Invest."},{"key":"4723_CR8","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/S0021-9258(17)42263-0","volume":"269","author":"MH Wong","year":"1994","unstructured":"Wong, M. H., Oelkers, P., Craddock, A. L. & Dawson, P. A. Expression cloning and characterization of the hamster ileal sodium-dependent bile acid transporter. J. Biol. Chem. 269, 1340\u20131347 (1994).","journal-title":"J. Biol. Chem."},{"key":"4723_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1515\/bc.2011.017","volume":"392","author":"W Kramer","year":"2011","unstructured":"Kramer, W. Transporters, Trojan horses and therapeutics: suitability of bile acid and peptide transporters for drug delivery. Biol. Chem. 392, 77\u201394 (2011).","journal-title":"Biol. Chem."},{"key":"4723_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1021\/mp034010t","volume":"1","author":"S Tolle-Sander","year":"2004","unstructured":"Tolle-Sander, S., Lentz, K. A., Maeda, D. Y., Coop, A. & Polli, J. E. Increased acyclovir oral bioavailability via a bile acid conjugate. Mol. Pharm. 1, 40\u201348 (2004).","journal-title":"Mol. Pharm."},{"key":"4723_CR11","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1053\/gast.1997.v113.pm9322525","volume":"113","author":"GA Kullak-Ublick","year":"1997","unstructured":"Kullak-Ublick, G. A. et al. Chlorambucil-taurocholate is transported by bile acid carriers expressed in human hepatocellular carcinomas. Gastroenterology 113, 1295\u20131305 (1997).","journal-title":"Gastroenterology"},{"key":"4723_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bmcl.2004.10.027","volume":"15","author":"L Bhat","year":"2005","unstructured":"Bhat, L., Jandeleit, B., Dias, T. M., Moors, T. L. & Gallop, M. A. Synthesis and biological evaluation of novel steroidal pyrazoles as substrates for bile acid transporters. Bioorg. Med. Chem. Lett. 15, 85\u201387 (2005).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"4723_CR13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1021\/mp060022d","volume":"3","author":"A Balakrishnan","year":"2006","unstructured":"Balakrishnan, A. & Polli, J. E. Apical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug target. Mol. Pharm. 3, 223\u2013230 (2006).","journal-title":"Mol. Pharm."},{"key":"4723_CR14","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1053\/j.gastro.2006.02.034","volume":"130","author":"RH Ho","year":"2006","unstructured":"Ho, R. H. et al. Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics. Gastroenterology 130, 1793\u20131806 (2006).","journal-title":"Gastroenterology"},{"key":"4723_CR15","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1211\/jpp.57.10.0009","volume":"57","author":"H Fujino","year":"2005","unstructured":"Fujino, H., Saito, T., Ogawa, S. & Kojima, J. Transporter-mediated influx and efflux mechanisms of pitavastatin, a new inhibitor of HMG-CoA reductase. J. Pharm. Pharmacol. 57, 1305\u20131311 (2005).","journal-title":"J. Pharm. Pharmacol."},{"key":"4723_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/hep.30792","volume":"71","author":"RLP Roscam Abbing","year":"2020","unstructured":"Roscam Abbing, R. L. P. et al. Blocking sodium-taurocholate cotransporting polypeptide stimulates biliary cholesterol and phospholipid secretion in mice. Hepatology 71, 247\u2013258 (2020).","journal-title":"Hepatology"},{"key":"4723_CR17","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jcmgh.2020.04.009","volume":"10","author":"JM Donkers","year":"2020","unstructured":"Donkers, J. M. et al. Inhibition of hepatic bile acid uptake by myrcludex B promotes glucagon-like peptide-1 release and reduces obesity. Cell. Mol. Gastroenterol. Hepatol. 10, 451\u2013466 (2020).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"4723_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.coviro.2016.06.003","volume":"18","author":"M Levrero","year":"2016","unstructured":"Levrero, M., Testoni, B. & Zoulim, F. HBV cure: why, how, when? Curr. Opin. Virol. 18, 135\u2013143 (2016).","journal-title":"Curr. Opin. Virol."},{"key":"4723_CR19","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1136\/gutjnl-2014-308943","volume":"64","author":"MB Zeisel","year":"2015","unstructured":"Zeisel, M. B. et al. Towards an HBV cure: state-of-the-art and unresolved questions-report of the ANRS workshop on HBV cure. Gut 64, 1314\u20131326 (2015).","journal-title":"Gut"},{"key":"4723_CR20","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/hep.21112","volume":"43","author":"M Engelke","year":"2006","unstructured":"Engelke, M. et al. Characterization of a hepatitis B and hepatitis delta virus receptor binding site. Hepatology 43, 750\u2013760 (2006).","journal-title":"Hepatology"},{"key":"4723_CR21","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1128\/JVI.73.3.2052-2057.1999","volume":"73","author":"J Le Seyec","year":"1999","unstructured":"Le Seyec, J., Chouteau, P., Cannie, I., Guguen-Guillouzo, C. & Gripon, P. Infection process of the hepatitis B virus depends on the presence of a defined sequence in the pre-S1 domain. J. Virol. 73, 2052\u20132057 (1999).","journal-title":"J. Virol."},{"key":"4723_CR22","doi-asserted-by":"publisher","first-page":"5841","DOI":"10.1128\/JVI.00096-07","volume":"81","author":"M Blanchet","year":"2007","unstructured":"Blanchet, M. & Sureau, C. Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues. J. Virol. 81, 5841\u20135849 (2007).","journal-title":"J. Virol."},{"key":"4723_CR23","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1128\/JVI.79.3.1613-1622.2005","volume":"79","author":"P Gripon","year":"2005","unstructured":"Gripon, P., Cannie, I. & Urban, S. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J. Virol. 79, 1613\u20131622 (2005).","journal-title":"J. Virol."},{"key":"4723_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nbt1389","volume":"26","author":"J Petersen","year":"2008","unstructured":"Petersen, J. et al. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nat. Biotechnol. 26, 335\u2013341 (2008).","journal-title":"Nat. Biotechnol."},{"key":"4723_CR25","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1128\/JVI.01902-09","volume":"84","author":"A Schulze","year":"2010","unstructured":"Schulze, A., Schieck, A., Ni, Y., Mier, W. & Urban, S. Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction. J. Virol. 84, 1989\u20132000 (2010).","journal-title":"J. Virol."},{"key":"4723_CR26","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1053\/j.gastro.2005.03.090","volume":"129","author":"D Glebe","year":"2005","unstructured":"Glebe, D. et al. Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes. Gastroenterology 129, 234\u2013245 (2005).","journal-title":"Gastroenterology"},{"key":"4723_CR27","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/nature10450","volume":"478","author":"NJ Hu","year":"2011","unstructured":"Hu, N. J., Iwata, S., Cameron, A. D. & Drew, D. Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBT. Nature 478, 408\u2013411 (2011).","journal-title":"Nature"},{"key":"4723_CR28","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nature12811","volume":"505","author":"X Zhou","year":"2014","unstructured":"Zhou, X. et al. Structural basis of the alternating-access mechanism in a bile acid transporter. Nature 505, 569\u2013573 (2014).","journal-title":"Nature"},{"key":"4723_CR29","doi-asserted-by":"publisher","first-page":"e40110","DOI":"10.7554\/eLife.40110","volume":"7","author":"E Cirri","year":"2018","unstructured":"Cirri, E. et al. Consensus designs and thermal stability determinants of a human glutamate transporter. eLife 7, e40110 (2018).","journal-title":"eLife"},{"key":"4723_CR30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41592-020-01001-6","volume":"18","author":"T Uchanski","year":"2021","unstructured":"Uchanski, T. et al. Megabodies expand the nanobody toolkit for protein structure determination by single-particle cryo-EM. Nat. Methods 18, 60\u201368 (2021).","journal-title":"Nat. Methods"},{"key":"4723_CR31","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1046\/j.1432-1033.2003.03463.x","volume":"270","author":"D Zahner","year":"2003","unstructured":"Zahner, D., Eckhardt, U. & Petzinger, E. Transport of taurocholate by mutants of negatively charged amino acids, cysteines, and threonines of the rat liver sodium-dependent taurocholate cotransporting polypeptide NTCP. Eur. J. Biochem. 270, 1117\u20131127 (2003).","journal-title":"Eur. J. Biochem."},{"key":"4723_CR32","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.1128\/JVI.03478-13","volume":"88","author":"H Yan","year":"2014","unstructured":"Yan, H. et al. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide. J. Virol. 88, 3273\u20133284 (2014).","journal-title":"J. Virol."},{"key":"4723_CR33","doi-asserted-by":"publisher","first-page":"34691","DOI":"10.1074\/jbc.273.52.34691","volume":"273","author":"SA Weinman","year":"1998","unstructured":"Weinman, S. A., Carruth, M. W. & Dawson, P. A. Bile acid uptake via the human apical sodium-bile acid cotransporter is electrogenic. J. Biol. Chem. 273, 34691\u201334695 (1998).","journal-title":"J. Biol. Chem."},{"key":"4723_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1055\/s-2007-1007226","volume":"16","author":"B Hagenbuch","year":"1996","unstructured":"Hagenbuch, B. & Meier, P. J. Sinusoidal (basolateral) bile salt uptake systems of hepatocytes. Semin. Liver Dis. 16, 129\u2013136 (1996).","journal-title":"Semin. Liver Dis."},{"key":"4723_CR35","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.1074\/jbc.M305782200","volume":"279","author":"RH Ho","year":"2004","unstructured":"Ho, R. H., Leake, B. F., Roberts, R. L., Lee, W. & Kim, R. B. Ethnicity-dependent polymorphism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition. J. Biol. Chem. 279, 7213\u20137222 (2004).","journal-title":"J. Biol. Chem."},{"key":"4723_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07012-2","volume":"7","author":"R Liu","year":"2017","unstructured":"Liu, R. et al. Homozygous p.Ser267Phe in SLC10A1 is associated with a new type of hypercholanemia and implications for personalized medicine. Sci. Rep. 7, 9214 (2017).","journal-title":"Sci. Rep."},{"key":"4723_CR37","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3109\/00498254.2011.555567","volume":"41","author":"W Pan","year":"2011","unstructured":"Pan, W. et al. Genetic polymorphisms in Na+-taurocholate co-transporting polypeptide (NTCP) and ileal apical sodium-dependent bile acid transporter (ASBT) and ethnic comparisons of functional variants of NTCP among Asian populations. Xenobiotica 41, 501\u2013510 (2011).","journal-title":"Xenobiotica"},{"key":"4723_CR38","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrm.2015.25","volume":"17","author":"EM Quistgaard","year":"2016","unstructured":"Quistgaard, E. M., Low, C., Guettou, F. & Nordlund, P. Understanding transport by the major facilitator superfamily (MFS): structures pave the way. Nat. Rev. Mol. Cell Biol. 17, 123\u2013132 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"4723_CR39","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1146\/annurev-biochem-060815-014520","volume":"85","author":"D Drew","year":"2016","unstructured":"Drew, D. & Boudker, O. Shared molecular mechanisms of membrane transporters. Annu. Rev. Biochem. 85, 543\u2013572 (2016).","journal-title":"Annu. Rev. Biochem."},{"key":"4723_CR40","first-page":"4915","volume":"20","author":"H Li","year":"2019","unstructured":"Li, H. et al. Clinical and molecular characterization of four patients with NTCP deficiency from two unrelated families harboring the novel SLC10A1 variant c.595A>C (p.Ser199Arg). Mol. Med. Rep. 20, 4915\u20134924 (2019).","journal-title":"Mol. Med. Rep."},{"key":"4723_CR41","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/hep.1840100408","volume":"10","author":"DA Novak","year":"1989","unstructured":"Novak, D. A., Ryckman, F. C. & Suchy, F. J. Taurocholate transport by basolateral plasma membrane vesicles isolated from human liver. Hepatology 10, 447\u2013453 (1989).","journal-title":"Hepatology"},{"key":"4723_CR42","first-page":"G157","volume":"274","author":"AL Craddock","year":"1998","unstructured":"Craddock, A. L. et al. Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am. J. Physiol. 274, G157\u2013G169 (1998).","journal-title":"Am. J. Physiol."},{"key":"4723_CR43","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1124\/dmd.109.031526","volume":"38","author":"YH Han","year":"2010","unstructured":"Han, Y. H. et al. Transporter studies with the 3-O-sulfate conjugate of 17\u03b1-ethinylestradiol: assessment of human kidney drug transporters. Drug Metab. Dispos. 38, 1064\u20131071 (2010).","journal-title":"Drug Metab. Dispos."},{"key":"4723_CR44","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/BF01869585","volume":"57","author":"P Lauger","year":"1980","unstructured":"Lauger, P. Kinetic properties of ion carriers and channels. J. Membr. Biol. 57, 163\u2013178 (1980).","journal-title":"J. Membr. Biol."},{"key":"4723_CR45","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0304-4157(97)00007-5","volume":"1331","author":"IC West","year":"1997","unstructured":"West, I. C. Ligand conduction and the gated-pore mechanism of transmembrane transport. Biochim. Biophys. Acta 1331, 213\u2013234 (1997).","journal-title":"Biochim. Biophys. Acta"},{"key":"4723_CR46","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1098\/rstb.2008.0245","volume":"364","author":"F Ashcroft","year":"2009","unstructured":"Ashcroft, F., Gadsby, D. & Miller, C. The blurred boundary between channels and transporters. Philos. Trans. R. Soc. B 364, 145\u2013147 (2009).","journal-title":"Philos. Trans. R. Soc. B"},{"key":"4723_CR47","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/jvh.13490","volume":"28","author":"D Cheng","year":"2021","unstructured":"Cheng, D., Han, B., Zhang, W. & Wu, W. Clinical effects of NTCP-inhibitor myrcludex B. J. Viral Hepat. 28, 852\u2013858 (2021).","journal-title":"J. Viral Hepat."},{"key":"4723_CR48","doi-asserted-by":"publisher","first-page":"e20200840","DOI":"10.1084\/jem.20200840","volume":"217","author":"V Hehle","year":"2020","unstructured":"Hehle, V. et al. Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllers. J. Exp. Med. 217, e20200840 (2020).","journal-title":"J. Exp. Med."},{"key":"4723_CR49","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.coviro.2018.04.002","volume":"30","author":"D Corti","year":"2018","unstructured":"Corti, D., Benigni, F. & Shouval, D. Viral envelope-specific antibodies in chronic hepatitis B virus infection. Curr. Opin. Virol. 30, 48\u201357 (2018).","journal-title":"Curr. Opin. Virol."},{"key":"4723_CR50","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/bioinformatics\/btp033","volume":"25","author":"AM Waterhouse","year":"2009","unstructured":"Waterhouse, A. M., Procter, J. B., Martin, D. M., Clamp, M. & Barton, G. J. Jalview version 2-a multiple sequence alignment editor and analysis workbench. Bioinformatics 25, 1189\u20131191 (2009).","journal-title":"Bioinformatics"},{"key":"4723_CR51","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1093\/nar\/gkh340","volume":"32","author":"RC Edgar","year":"2004","unstructured":"Edgar, R. C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32, 1792\u20131797 (2004).","journal-title":"Nucleic Acids Res."},{"key":"4723_CR52","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.str.2012.06.009","volume":"20","author":"M Hattori","year":"2012","unstructured":"Hattori, M., Hibbs, R. E. & Gouaux, E. A fluorescence-detection size-exclusion chromatography-based thermostability assay for membrane protein precrystallization screening. Structure 20, 1293\u20131299 (2012).","journal-title":"Structure"},{"key":"4723_CR53","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature22064","volume":"544","author":"JC Canul-Tec","year":"2017","unstructured":"Canul-Tec, J. C. et al. Structure and allosteric inhibition of excitatory amino acid transporter 1. Nature 544, 446\u2013451 (2017).","journal-title":"Nature"},{"key":"4723_CR54","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0076-6879(09)64011-8","volume":"464","author":"TK Ritchie","year":"2009","unstructured":"Ritchie, T. K. et al. Reconstitution of membrane proteins in phospholipid bilayer nanodiscs. Methods Enzymol. 464, 211\u2013231 (2009).","journal-title":"Methods Enzymol."},{"key":"4723_CR55","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nprot.2014.039","volume":"9","author":"E Pardon","year":"2014","unstructured":"Pardon, E. et al. A general protocol for the generation of nanobodies for structural biology. Nat. Protoc. 9, 674\u2013693 (2014).","journal-title":"Nat. Protoc."},{"key":"4723_CR56","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1002\/jps.23933","volume":"103","author":"T De Bruyn","year":"2014","unstructured":"De Bruyn, T. et al. Confocal imaging with a fluorescent bile acid analogue closely mimicking hepatic taurocholate disposition. J. Pharm. Sci. 103, 1872\u20131881 (2014).","journal-title":"J. Pharm. Sci."},{"key":"4723_CR57","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2133\/dmpk.25.214","volume":"25","author":"K Yamaguchi","year":"2010","unstructured":"Yamaguchi, K., Murai, T., Yabuuchi, H., Hui, S. P. & Kurosawa, T. Measurement of bile salt export pump transport activities using a fluorescent bile acid derivative. Drug Metab. Pharmacokinet. 25, 214\u2013219 (2010).","journal-title":"Drug Metab. Pharmacokinet."},{"key":"4723_CR58","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","volume":"152","author":"DN Mastronarde","year":"2005","unstructured":"Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36\u201351 (2005).","journal-title":"J. Struct. Biol."},{"key":"4723_CR59","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"4723_CR60","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/s41592-020-00990-8","volume":"17","author":"A Punjani","year":"2020","unstructured":"Punjani, A., Zhang, H. & Fleet, D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 17, 1214\u20131221 (2020).","journal-title":"Nat. Methods"},{"key":"4723_CR61","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"4723_CR62","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/pro.3235","volume":"27","author":"TD Goddard","year":"2018","unstructured":"Goddard, T. D. et al. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 27, 14\u201325 (2018).","journal-title":"Protein Sci."},{"key":"4723_CR63","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D"},{"key":"4723_CR64","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr. D"},{"key":"4723_CR65","doi-asserted-by":"publisher","first-page":"W402","DOI":"10.1093\/nar\/gkz297","volume":"47","author":"DWA Buchan","year":"2019","unstructured":"Buchan, D. W. A. & Jones, D. T. The PSIPRED protein analysis workbench: 20 years on. Nucleic Acids Res. 47, W402\u2013W407 (2019).","journal-title":"Nucleic Acids Res."},{"key":"4723_CR66","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nmeth.3213","volume":"12","author":"J Yang","year":"2015","unstructured":"Yang, J. et al. The I-TASSER suite: protein structure and function prediction. Nat. Methods 12, 7\u20138 (2015).","journal-title":"Nat. Methods"},{"key":"4723_CR67","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr. D"},{"key":"4723_CR68","doi-asserted-by":"publisher","first-page":"W363","DOI":"10.1093\/nar\/gky473","volume":"46","author":"W Tian","year":"2018","unstructured":"Tian, W., Chen, C., Lei, X., Zhao, J. & Liang, J. CASTp 3.0: computed atlas of surface topography of proteins. Nucleic Acids Res. 46, W363\u2013W367 (2018).","journal-title":"Nucleic Acids Res."},{"key":"4723_CR69","doi-asserted-by":"publisher","first-page":"W368","DOI":"10.1093\/nar\/gky309","volume":"46","author":"L Pravda","year":"2018","unstructured":"Pravda, L. et al. MOLEonline: a web-based tool for analyzing channels, tunnels and pores (2018 update). Nucleic Acids Res. 46, W368\u2013W373 (2018).","journal-title":"Nucleic Acids Res."},{"key":"4723_CR70","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","volume":"372","author":"E Krissinel","year":"2007","unstructured":"Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774\u2013797 (2007).","journal-title":"J. Mol. Biol."},{"key":"4723_CR71","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/bioinformatics\/19.1.163","volume":"19","author":"F Glaser","year":"2003","unstructured":"Glaser, F. et al. ConSurf: identification of functional regions in proteins by surface-mapping of phylogenetic information. Bioinformatics 19, 163\u2013164 (2003).","journal-title":"Bioinformatics"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-04723-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-04723-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-04723-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T16:14:10Z","timestamp":1656519250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-04723-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":71,"journal-issue":{"issue":"7916","published-print":{"date-parts":[[2022,6,30]]}},"alternative-id":["4723"],"URL":"https:\/\/doi.org\/10.1038\/s41586-022-04723-z","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,11]]},"assertion":[{"value":"19 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.G., F.S.I., E.P., J.S. and N.R. are listed as co-inventors on a patent application (22151078.7) by Institut Pasteur and VIB-VUB Center for Structural Biology related to the nanobodies used in this work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}